Abstract: BACKGROUND
Emergence of SARS COV 2 pandemic from china since December 2019 has endangered all human lives. COVID 19 is an acute respiratory disease that can lead to respiratory failure and death. COVID 19 patients with diabetes, COPD, CAD, hypertension, and other comorbidities develop a life threatening situation. The main objective of this study is to describe clinical characteristics and final outcomes for patients with COVID 19 infection and comorbid illness......
Keywords: covid 19,comorbidities , outcomes
[1]. Lohia, P., Sreeram, K., Nguyen, P., Choudhary, A., Khicher, S., Yarandi, H., Kapur, S. and Badr, M., 2021. Preexisting respiratory diseases and clinical outcomes in COVID-19: a multihospital cohort study on predominantly African American population. Respiratory Research, 22(1).
[2]. Ye, C., Zhang, S., Zhang, X., Cai, H., Gu, J., & Lian, J. et al. (2020). Impact of comorbidities on patients with COVID‐19: A large retrospective study in Zhejiang, China. Journal Of Medical Virology, 92(11), 2821-2829. doi: 10.1002/jmv.26183.
[3]. Alkhathami, M., Advani, S., Abalkhail, A., Alkhathami, F., Alshehri, M., Albeashy, E., & Alsalamah, J. (2021). Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis. Lung India, 38(7), 31. doi: 10.4103/lungindia.lungindia_497_20.
[4]. Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., & Abdalla, A. et al. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal Of Infection And Public Health, 13(12), 1833-1839. doi: 10.1016/j.jiph.2020.07.014.
[5]. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. Pediatria i Medycyna Rodzinna. 2020;16(1).